106 related articles for article (PubMed ID: 356361)
1. [Genetic nature of neoplastic transformation].
Shapot VS; Likhtenshteĭn AV
Tsitol Genet; 1978; 12(1):73-84. PubMed ID: 356361
[TBL] [Abstract][Full Text] [Related]
2. [Molecular-genetic nature of neoplastic transformation].
Shapot VS; Krechetova GD; Likhtenshteĭn AV; Shliankevich MA
Patol Fiziol Eksp Ter; 1976; (2):3-11. PubMed ID: 1024187
[No Abstract] [Full Text] [Related]
3. The regulation of a cellular protein, p53, in normal and transformed cells.
Levine AJ; Reich N; Thomas R
Prog Clin Biol Res; 1983; 119():159-69. PubMed ID: 6306685
[No Abstract] [Full Text] [Related]
4. A disrupted expression in cancers: multiple potential causes.
Dupasquier S; Quittau-Prévostel C
C R Biol; 2009 Jan; 332(1):1-14. PubMed ID: 19200921
[TBL] [Abstract][Full Text] [Related]
5. [Cell transformation by oncogenic DNA viruses].
Westphal H
Zentralbl Bakteriol Orig A; 1972 May; 220(1):27-38. PubMed ID: 4122875
[No Abstract] [Full Text] [Related]
6. [Genome instability and neoplasia].
Shapot VS; Mironov NM
Tsitol Genet; 1981; 15(6):73-83. PubMed ID: 6275583
[TBL] [Abstract][Full Text] [Related]
7. [Mouse teratocarcinoma: cytogenetic studies of multipotential cells (author's transl)].
Guénet JL; Jakob H; Nicolas JF; Jacob F
Ann Microbiol (Paris); 1974; 125A(2):135-51. PubMed ID: 4473078
[No Abstract] [Full Text] [Related]
8. [Malignant cell transformation and oncogenes].
Kiselev FL
Genetika; 1985 Jun; 21(6):885-95. PubMed ID: 3928437
[TBL] [Abstract][Full Text] [Related]
9. Tumor reversal in plants.
Meins F
Prog Clin Biol Res; 1982; 85 Pt B():567-76. PubMed ID: 7122580
[No Abstract] [Full Text] [Related]
10. Murine teratocarcinoma and the developmental approach to neoplasia.
Manes C
Cancer Res; 1976 Nov; 36(11 Pt. 2):4206-7. PubMed ID: 975057
[No Abstract] [Full Text] [Related]
11. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
12. Suppressors of the malignant phenotype.
Mikkelsen T; Cavenee WK
Cell Growth Differ; 1990 Apr; 1(4):201-7. PubMed ID: 2128032
[No Abstract] [Full Text] [Related]
13. Phenotypic modulation of keratins, vimentin, and alpha-fetoprotein in cultured rat liver epithelial cells after chemical, oncogene, and spontaneous transformation.
Bisgaard HC; Ton PT; Nagy P; Thorgeirsson SS
J Cell Physiol; 1994 Jun; 159(3):485-94. PubMed ID: 7514612
[TBL] [Abstract][Full Text] [Related]
14. Mammalian homeobox genes in normal development and neoplasia.
Deschamps J; Meijlink F
Crit Rev Oncog; 1992; 3(1-2):117-73. PubMed ID: 1372520
[TBL] [Abstract][Full Text] [Related]
15. [1 of the pathways for normalization of populations of malignant cells].
Shuklinov VA
Tsitologiia; 1985 Mar; 27(3):268-75. PubMed ID: 3887700
[TBL] [Abstract][Full Text] [Related]
16. [Double-mutation hypothesis of carcinogenesis].
Strunnikov VA; Uryvaeva IV; Brodskiĭ VIa
Tsitol Genet; 1984; 18(5):380-91. PubMed ID: 6390888
[TBL] [Abstract][Full Text] [Related]
17. Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro.
Luber B; Arnold N; Stürzl M; Höhne M; Schirmacher P; Lauer U; Wienberg J; Hofschneider PH; Kekulé AS
Oncogene; 1996 Apr; 12(8):1597-608. PubMed ID: 8622879
[TBL] [Abstract][Full Text] [Related]
18. Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1.
Ordway JM; Williams K; Curran T
Oncogene; 2004 May; 23(21):3737-48. PubMed ID: 14990994
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of tumours derived from rasV12/E1A-transformed mouse embryonic fibroblasts to identify genes required for tumour development.
Vasseur S; Malicet C; Calvo EL; Dagorn JC; Iovanna JL
Mol Cancer; 2005 Jan; 4(1):4. PubMed ID: 15651998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
